Press Releases

Modular automation solution adds PACE to just-in-time clinical trials packing

A new modular automation system for clinical trials drug delivery – now in operation at the Medical Manufacturing Innovation Centre (MMIC) in Strathclyde – is giving pharmaceutical and life sciences a game-changing insight into a future where new products can be delivered faster, more flexibly and cheaper than before.

Andelyn Biosciences and Armatus Bio Partner to Manufacture Suspension-Based AAV Gene Therapy for Rare Neurological Disease Charcot-Marie-Tooth Type 1A (CMT1A)

Andelyn Biosciences and Armatus Bio are partnering to accelerate the manufacturing of a suspension-based AAV gene therapy for Charcot-Marie-Tooth Type 1A (CMT1A), a rare neurological disease. The collaboration aims to maximize program efficiency and speed up clinical studies using Andelyn's expertise in AAV production and suspension platform. The initiative brings hope to patients with unmet needs in neuromuscular diseases.

New Multi-Hospital Partner Joins OneMedNet’s Expansive Real World Data Network

OneMedNet Corporation announced a partnership with Beacon Health System, Inc. to promote new patient care diagnostic and treatment solutions using OneMedNet’s iRWD™. Life Science organizations of all types are taking advantage of existing real world data within several product development stages including conceptualization, development, validation, regulatory approval, and post-market surveillance. The OneMedNet iRWD network consists of over 235 healthcare systems and providers who are well-recognized for their exceptional patient care.

Blue Spark Technologies Adds MaryAnne Rizk to Board of Advisors

Blue Spark Technologies, Inc., a proven innovative digital health technology (DHT) leader in enabling AI-powered remote patient monitoring (RPM) to support precision patient-centric drug development, proudly announces the appointment of Dr. MaryAnne Rizk, a recognized leader in drug development technological innovation, to the Company’s advisory board.

Bio-Link and Verdot Forge Strategic Partnership to Advance Bioprocessing Technologies in China

I wanted to reach out with the latest news from Verdot, who have recently forged a strategic partnership with Bio-Link, a prominent Chinese bioprocessing company. The collaboration aims to advance biopharmaceutical manufacturing in China, with Bio-Link becoming the major distributor for Verdot’s innovative chromatography columns in the Chinese market The full release and images are below. Thank you Charlotte

CD Genomics Introduces Advanced OxBS-seq Technology for Accurate Methylation Analysis

CD Genomics Unveils Groundbreaking Total RNA Sequencing and Dual RNA-seq Services

Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)

— Results Demonstrated that LYBALVI was Generally Well Tolerated With Stability of Body Weight and Metabolic Profile, and Durable Symptom Control, for Up to Four Years of Treatment —

Elligo Health Research Announces New CEO

John Potthoff Transitions to Chairman, Barry Simms Promoted to CEO

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults. Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.1,2 Rezafungin represents the first new treatment option in over 15 years for patients with invasive candidiasis.3

CD Formulation Extends Holiday Greetings for 2023 with an Exclusive Discount

Alfa Chemistry Launches Varieties of Biological Reagents for Use in Nucleic Acid Purification Systems

BOC Sciences and Spaya Join Forces to Expand Chemical Offerings

BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.

Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

Dr. Vince Clinical Research Launches New Solution for Organ Impairment Studies

Huateng Pharma Introduces Versatile Ingredients for Cosmetics and Commodities

Huateng Pharma introduces Tetrahydrocurcumin, a dual-action antioxidant and skin-whitening agent, alongside Pro-xylane and (S)-Pro-xylane, potent anti-ageing agents, and Piroctone Olamine, an effective anti-dandruff solution, emphasizing a commitment to quality and versatility from lab to commercial scale.

Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome

Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).

Creative Biostructure Unveils Comprehensive Panel of Exosomes Isolated from Human Disease-State Body Fluids

Matexcel Provides Expansive Array of Bio-ink Products for Different Applications

Lifeasible Simplifies Gene Editing with CRISPR Mutation Library Construction Services